AGT and COVID-19: Oudit and coworkers, as well as Lanza and collaborators [54,55], indeed, suggested that SARS-CoV2 disease (COVID-19), through ACE2 involvement in the intracellular entry of the virus, may be effective in inducing a prevalence of Ang II compared to the amount of Ang 1-7.